These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Steffel J; Latini RA; Akhmedov A; Zimmermann D; Zimmerling P; Lüscher TF; Tanner FC Circulation; 2005 Sep; 112(13):2002-11. PubMed ID: 16172265 [TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats. Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576 [TBL] [Abstract][Full Text] [Related]
26. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway. Ji Y; Liu J; Wang Z; Li Z Cytokine; 2011 Sep; 55(3):409-19. PubMed ID: 21700474 [TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation. Ku YH; Cho BJ; Kim MJ; Lim S; Park YJ; Jang HC; Choi SH BMC Pharmacol Toxicol; 2017 Aug; 18(1):62. PubMed ID: 28854981 [TBL] [Abstract][Full Text] [Related]
28. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581 [TBL] [Abstract][Full Text] [Related]
29. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228 [TBL] [Abstract][Full Text] [Related]
30. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY. Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes. Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446 [TBL] [Abstract][Full Text] [Related]
32. PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring. Liu J; Sakurai R; Rehan VK Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(8):L788-96. PubMed ID: 25659902 [TBL] [Abstract][Full Text] [Related]
33. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Liu D; Zeng BX; Zhang SH; Yao SL Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220 [TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Guha M; O'Connell MA; Pawlinski R; Hollis A; McGovern P; Yan SF; Stern D; Mackman N Blood; 2001 Sep; 98(5):1429-39. PubMed ID: 11520792 [TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone regulates c-reactive protein-induced inflammatory responses via glucocorticoid receptor-mediated inhibition of p38 mitogen-activated protein kinase-toll-like receptor 4 signal pathway in vascular smooth muscle cells. Liu N; Liu JT; Ji YY; Lu PP J Cardiovasc Pharmacol; 2011 Mar; 57(3):348-56. PubMed ID: 21383592 [TBL] [Abstract][Full Text] [Related]
37. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice. Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889 [TBL] [Abstract][Full Text] [Related]
38. Stimulation of the peroxisome proliferator-activated receptor gamma (PPAR gamma) and the expression of selected blood monocyte cytokine genes in diabetic macroangiopathy. Adamiec R; Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Sadakierska-Chudy A Atherosclerosis; 2007 Oct; 194(2):e108-15. PubMed ID: 17141246 [TBL] [Abstract][Full Text] [Related]
39. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643 [TBL] [Abstract][Full Text] [Related]
40. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways. Zhu W; Yan H; Li S; Nie W; Fan F; Zhu J Int Immunopharmacol; 2016 Dec; 41():24-34. PubMed ID: 27792919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]